title: Recognition and treatment of acute alcohol withdrawal syndromes.
abstract: The alcohol withdrawal syndromes are generally self-limited processes from which spontaneous recovery can be anticipated. To achieve this outcome, the various types of withdrawal must be managed in such a way as to prevent the occurrence of life-threatening situations. This begins with a good initial evaluation, followed by the appropriate pharmacologic and behavioral steps to control the severity of withdrawal symptoms and to manage complications. Once the withdrawal process is completed, the patient can then be entered into a long-term treatment program.
mesh_terms: D000208:Acute Disease; D000430:Alcohol Withdrawal Delirium / Q000175:diagnosis; D000437:Alcoholism / Q000150:complications / Q000175:diagnosis; D001569:Benzodiazepines / Q000627:therapeutic use; D002697:Chloral Hydrate / Q000627:therapeutic use; D000431:Ethanol / Q000009:adverse effects*; D005492:Folic Acid / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D009748:Nutrition Disorders / Q000188:drug therapy / Q000209:etiology; D012640:Seizures / Q000139:chemically induced; D012944:Social Support; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*; D013831:Thiamine / Q000627:therapeutic use; D014812:Vitamin K / Q000627:therapeutic use; D014883:Water-Electrolyte Imbalance / Q000209:etiology / Q000628:therapy
chemical_list: D014812:Vitamin K; D001569:Benzodiazepines; D000431:Ethanol; D002697:Chloral Hydrate; D005492:Folic Acid; D013831:Thiamine